Dan Lou
Directeur/Membre du Conseil chez China Medicinal Biotech Association
Profil
Dan Lou was the founder of Shenyang Sunshine Pharmaceuticals Co., Ltd.
founded in 1993 and 3SBio, Inc. founded in 1993 where he held the title of Executive Chairman from 2011 to 2012.
He currently holds a position as Executive Director at China Medicinal Biotech Association.
Mr. Lou received his undergraduate degree from Third Military Medical University in 1955.
Postes actifs de Dan Lou
| Sociétés | Poste | Début |
|---|---|---|
| China Medicinal Biotech Association | Directeur/Membre du Conseil | 18/10/2011 |
Anciens postes connus de Dan Lou
| Sociétés | Poste | Fin |
|---|---|---|
| 3SBIO INC. | Fondateur | 01/04/2012 |
Shenyang Sunshine Pharmaceuticals Co., Ltd.
 Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | Fondateur | - |
Formation de Dan Lou
| Third Military Medical University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| 3SBIO INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
| China Medicinal Biotech Association | |
Shenyang Sunshine Pharmaceuticals Co., Ltd.
Shenyang Sunshine Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Shenyang Sunshine Pharmaceutical Co., Ltd. engages in the development and production of biological products. It offers recombinant human erythropoietin, interferon alfa 2b, interleukin 2, and thrombopoietin injections. Its business activities include research and development, and manufacture of biochemical reagents, and pharmaceutical project investment advisory services. The company was founded on January 3, 1993 and is headquartered in Shenyang, China. | Health Technology |